跳至主要内容
临床试验/TCTR20230411002
TCTR20230411002Unknown1 期

The effect of hyoscine butylbromide for shortening active phase of the first stage of labor : Double blind placebo-controlled trial

khonkaen hospital0 个研究点目标入组 120 人开始时间: 2023年4月11日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Singleton pregnant women >18 years old
  • term pregnancy with a cephalic presentation and planned vaginal delivery

排除标准

  • High risk pregnancy with contraindication to vaginal delivery e.g., placenta previa, Previous uterine surgery, Cephalopelvic disproportion
  • Pregnancy women who received Epidural anesthesia.
  • Pregnancy women with high risk for unstable fetal status e.g., Placental abruption, Meconium stained amniotic fluid, Fetal anomaly, Non reassuring fetal status
  • Pregnancy women with contraindications for hyoscine-N-Butylbromide
  • Pregnancy women who has infection, chronic disease or pregnancy- induced diseases e.g., Maternal fever (Body temperature more than 37.8 degree celcius), Thyroid disease, cardiovascular disease, Autoimmune disease, Gestational diabetes mellitus, Pregnancy induced hypertension.

研究者

发起方
khonkaen hospital

相似试验